April 12, 2011 -- Aoxing Pharma, a US headquartered pharma with China operations in Hebei province, is a company with a lot of promise, but its actual performance has been an exercise in patience. The company has a very rare license to produce narcotics and other pain medications, one of just 13 PRC pharmas to possess one. So, Aoxing ought to be doing well, right? But the company reported just $3.8 million of revenue during the first months of its fiscal year. And costs of selling its products rose at a faster rate than its revenues. More details....
Stock Symbol: (AMEX: AXN)
